{{Rsnum
|rsid=2304277
|Chromosome=3
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=OGG1
|position=9759396
|Gene_s=CAMK1,OGG1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 5.3 | 26.5 | 68.1
| HCB | 36.5 | 46.0 | 17.5
| JPT | 21.2 | 54.0 | 24.8
| YRI | 15.6 | 46.3 | 38.1
| ASW | 8.8 | 47.4 | 43.9
| CHB | 36.5 | 46.0 | 17.5
| CHD | 27.5 | 52.3 | 20.2
| GIH | 13.9 | 43.6 | 42.6
| LWK | 18.2 | 42.7 | 39.1
| MEX | 8.6 | 55.2 | 36.2
| MKK | 21.2 | 44.9 | 34.0
| TSI | 1.0 | 33.3 | 65.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24698998
  |Trait=Ovarian cancer
  |Title=DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
  |RiskAllele=A
  |Pval=4.8E-3
  |OR=1.12
  |ORtxt=[1.03-1.21]
  |OA=1
}}
Modifies risk of ovarian cancer in [[BRCA1]] mutation carriers, study size 23,463 mutation carriers {{PMID|24698998|OA=1
}}.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}